Authors/Disclosures
|
Xuemei Cai, MD, FAAN
(Tufts Medical Center)
|
Dr. Cai has received personal compensation for serving as an employee of Pfizer. Dr. Cai has stock in Pfizer. |
|
Steve W. Han, MD PhD
(Takeda Pharmaceuticals)
|
No disclosure on file |
|
Sherry Hsiang-Yi Chou, MD
(Departmnt of Neurology, Northwestern Feinberg School of Medicine)
|
Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of NIH. An immediate family member of Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of Wells Fargo. Dr. Hsiang-Yi Chou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Therapeutics. The institution of Dr. Hsiang-Yi Chou has received research support from The Neurocritical Care Society. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Board of Director member with United Council of Neurologic Specialties that is relevant to AAN interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair-elect, the Neurocritical Care Committee with American Heart Association, the Stroke Council that is relevant to AAN interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair ellect, the Neurocritical Care Special Interest Group with American Neurologic Association that is relevant to AAN interests or activities. |
|
Mark F. Gordon, MD, FAAN
(Teva Pharmaceuticals)
|
Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva. |
|
|
No disclosure on file |